Ukrainian Antarctic Journal

No 14 (2015): Ukrainian Antarctic Journal
Articles

Perspective of usage of PPARγ agonists melanin and pioglitazone under the prolonged gastric hypoacidity

PDF (Українська)
  • O.I. Tsyryuk,
  • T.V. Beregova
O.I. Tsyryuk
ESC “Institute of Biology” of Taras Shevchenko National University of Kyiv, 64/13, Volodymyrska Str., Kyiv, 01601, Ukraine
T.V. Beregova
ESC “Institute of Biology” of Taras Shevchenko National University of Kyiv, 64/13, Volodymyrska Str., Kyiv, 01601, Ukraine
DOI: https://doi.org/10.33275/1727-7485.14.2015.191
Published December 31, 2015
Keywords
  • gastric secretion,
  • gastrin,
  • pioglitazone,
  • melanin
How to Cite
Tsyryuk, O., & Beregova, T. (2015). Perspective of usage of PPARγ agonists melanin and pioglitazone under the prolonged gastric hypoacidity. Ukrainian Antarctic Journal, (14), 185-188. https://doi.org/10.33275/1727-7485.14.2015.191
Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Abstract

It was investigated the effects of agonists of nuclear receptors peroxisome proliferator-activated receptors gamma (PPARγ) melanin and pioglitazone оn the secretory function of the stomach in rats under long hypoacidity of gastric juices caused bу the introduction of Н+-К+- ATPase blocker omeprazole during 28 days. As а result of studies it was found that administration of omeprazole for 28 days leads to increase of hydrochloric acid secretion of stomach, resulting in the development of hypergastrinemia. Activation of PPARy Bу pioglitazone and melanin in the conditions of the development of experimental hypergastrinemia prevents the hypertrophy of the gastric mucosa and decreases debit of the basal gastric acid secretion in rats.

PDF (Українська)

References

  1. Berehova, T.V., Tsyriuk, O.I., Voronina, O.K. et al. (2008). Strukturno-funktsionalni zminy v shlunku, vyklykani tryvaloiu hiperhastrynemiieiu, ta poshuk metodiv yikh profilaktyky [Structure and function changes in the stomach induced by long-term hypergastrinemia ]. Tezy dopovidei IY Mizhnarodnoi Konferentsii “Psykholofiziolohichni ta vistseralni funktsii v normi i patolohii”, prysviachenoi 90-richchiu vid dnia narodzhennia P. H. Bohacha, 43-44.
  2. Glancz, S. (1998). Mediko-biologicheskaya statistika [Medico-bological statistics]. Moscow, Praktika.
  3. Yevropeiska konventsiia pro zakhyst khrebetnykh tvaryn, shcho vykorystovuiutsia dlia doslidnykh ta inshykh naukovykh tsilei. [European convention on the protection of vertebrates used for research and other scientific aims] V kn. Murzin, O.B. Posibnyk do praktychnykh zaniat z fiziolohii liudyny. D.: Vydavnytstvo Dnipropetrovskoho universytetu, 2004. 135-148.
  4. Chyzhanska, N.V., Berehova, T.V., & Tsyriuk, O.I. (2005). Pro uchast oksydu azotu v tsytoprotektornii dii melaninu na slyzovu obolonku shlunka [On the involvement of nitrogen in the cytoprotectory action of melanin on the stomach mucose layer]. Visnyk problem biolohii i medytsyny, 3, 56-59.
  5. Ghosh, M.N., & Shild, H.O. (1958). Continuous recording of acid gastric secretion in the rat. British Journal of Pharmacology, 13-14.
  6. Harris, S.G. & Phipps, R.P. (2001). The nuclear receptor PPAR gamma is expressed by mouse T lymphocytes and PPAR gamma agonists induce apoptosis. European Journal of Immunology, 1098-1105.
  7. Jalving, M., Koornstra, J.J., Wesseling, J. et al. (2006). Increased risk of fundic gland polyps during long-term proton pump inhibitor therapy. Alimentary Pharmacology & Therapeutics, 24(9), 1341-1348.
  8. Jianu, C.S., Fossmark, R., Viset, T. et al. (2012). Gastric carcinoids after long-term use of a proton pump inhibitor. Alimentary Pharmacology & Therapeutics, 36(7), 644-649.
  9. Johnson, A.G., Jick, S.S., Perera, D.R. et al. (1996). Histamine-2 receptor antagonists and gastric cancer. Epidemiology, 7(4), 434-436.
  10. Konturek, P.C., Brzozowski, T., & Kania, J. (2003). Pioglitazone, a specific ligand of peroxisome proliferator-activated receptor-gamma, accelerates gastric ulcer healing in rat. European Journal of Pharmacology, 3, 213-220.
  11. Plonska, P., & Grabacka, M. (2006). Melanin synthesis in microorganisms - biotechnological and medical aspects. Acta Biochimica Polonica, 53(3), 429-443.
  12. Sertznig, P. (2007). Present concepts and future outlook: Function of peroxisome proliferators-activated receptors (PPARs) for pathogenesis, progression, and therapy of cancer. Journal of Cell Biology, 212, 1-12.
  13. Yang, XY, Wang, LH, Chen, T. et al. (2000). Activation of human T lymphocytes is inhibited by peroxisome proliferator activated receptor gamma (PPARgamma) agonists. PPARgamma coassociation with transcription factor NFAT. Journal of Biological Chemistry, 275, 4541-4544.